for those in the AD WGT following, do your DD w/o dismissing it as irrelevant, on ALZ-801 which is in phase 3 already and will be finished June 2024. Pill form, impressive phase 2 clinical improvement.
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects
Fully Enrolled Pivotal APOLLOE4 Phase 3 Trial Progressing Successfully, Enabling Topline Data Readout and NDA Filing in 2024
tempus fugit Rett is our savior...".where's the beef"
Market Data 
Markets 
AI
